Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2003 1
2004 3
2005 2
2006 1
2008 1
2009 1
2011 3
2012 2
2014 2
2015 3
2016 2
2017 3
2018 1
2019 3
2020 1
2021 3
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Refractory Hairy Cell Leukemia Variant"
Page 1
Hairy cell leukemia: 2020 update on diagnosis, risk stratification, and treatment.
Maitre E, Cornet E, Troussard X. Maitre E, et al. Am J Hematol. 2019 Dec;94(12):1413-1422. doi: 10.1002/ajh.25653. Epub 2019 Oct 31. Am J Hematol. 2019. PMID: 31591741 Free article. Review.
DISEASE OVERVIEW: Hairy cell leukemia (HCL) and HCL-like disorders, including HCL variant (HCL-V) and splenic diffuse red pulp lymphoma (SDRPL), are a very heterogeneous group of mature lymphoid B-cell disorders. They are characterized by the id …
DISEASE OVERVIEW: Hairy cell leukemia (HCL) and HCL-like disorders, including HCL variant (HCL-V) and splenic di …
Hairy cell leukemia 2022: Update on diagnosis, risk-stratification, and treatment.
Troussard X, Maître E, Cornet E. Troussard X, et al. Am J Hematol. 2022 Feb 1;97(2):226-236. doi: 10.1002/ajh.26390. Epub 2021 Nov 8. Am J Hematol. 2022. PMID: 34710243 Free article.
DISEASE OVERVIEW: Hairy cell leukemia (HCL) and HCL-like disorders, including HCL variant (HCL-V) and splenic diffuse red pulp lymphoma (SDRPL), are a very heterogeneous group of mature lymphoid B-cell disorders characterized by the identificati …
DISEASE OVERVIEW: Hairy cell leukemia (HCL) and HCL-like disorders, including HCL variant (HCL-V) and splenic di …
Treatment of hairy cell leukemia.
Chihara D, Kreitman RJ. Chihara D, et al. Expert Rev Hematol. 2020 Oct;13(10):1107-1117. doi: 10.1080/17474086.2020.1819231. Epub 2020 Sep 24. Expert Rev Hematol. 2020. PMID: 32893700 Review.
INTRODUCTION: Purine analogs made dramatic improvements for patients with hairy cell leukemia (HCL), but patients often relapse, require multiple treatments, and may become refractory. Major developments in treatment of relapsed/refractory HCL o …
INTRODUCTION: Purine analogs made dramatic improvements for patients with hairy cell leukemia (HCL), but patients often …
Hairy cell leukaemia-variant: Disease features and treatment.
Matutes E, Martínez-Trillos A, Campo E. Matutes E, et al. Best Pract Res Clin Haematol. 2015 Dec;28(4):253-63. doi: 10.1016/j.beha.2015.09.002. Epub 2015 Oct 8. Best Pract Res Clin Haematol. 2015. PMID: 26614904 Review.
Hairy cell leukaemia-variant (HCL-V) is a rare B-cell malignancy that affects elderly males and manifests with splenomegaly, lymphocytosis and cytopenias without monocytopenia. The neoplastic cells have morphological features of prolymphocytes a
Hairy cell leukaemia-variant (HCL-V) is a rare B-cell malignancy that affects elderly males and manifests
Hairy Cell Leukemia (HCL) and HCL Variant: Updates and Spotlights on Therapeutic Advances.
Paillassa J, Maitre E, Troussard X. Paillassa J, et al. Curr Oncol Rep. 2022 Sep;24(9):1133-1143. doi: 10.1007/s11912-022-01285-1. Epub 2022 Apr 11. Curr Oncol Rep. 2022. PMID: 35403971 Review.
PURPOSE OF REVIEW: This article aims to bring an update on the recent discoveries in hairy cell leukemia (HCL), especially findings in pathophysiology and therapeutic advances. ...These findings led to the development of new targeted therapies which have show …
PURPOSE OF REVIEW: This article aims to bring an update on the recent discoveries in hairy cell leukemia (HCL), especia …
Advances in the Treatment of Hairy Cell Leukemia Variant.
Tran J, Gaulin C, Tallman MS. Tran J, et al. Curr Treat Options Oncol. 2022 Jan;23(1):99-116. doi: 10.1007/s11864-021-00927-z. Epub 2022 Feb 18. Curr Treat Options Oncol. 2022. PMID: 35178674 Review.
Hairy cell leukemia variant (HCL-V) is a rare B cell lymphoproliferative disorder with a clinical-pathological distinction from the classic form of hairy cell leukemia (HCL-C). HCL-V is more aggressive in nature, has
Hairy cell leukemia variant (HCL-V) is a rare B cell lymphoproliferative disorder with a clinical-
Refractory hairy cell leukemia-variant.
Hu Z, Sun Y, Wang W, Medeiros LJ, Kanagal-Shamanna R. Hu Z, et al. Am J Hematol. 2017 Dec;92(12):1398-1399. doi: 10.1002/ajh.24580. Epub 2016 Nov 12. Am J Hematol. 2017. PMID: 27727469 Free article. No abstract available.
Hairy cell leukemia: a 'hair-raising' update.
Topp ZZ, Saven A. Topp ZZ, et al. Expert Rev Hematol. 2014 Oct;7(5):659-69. doi: 10.1586/17474086.2014.951629. Epub 2014 Aug 22. Expert Rev Hematol. 2014. PMID: 25148599 Review.
Hairy cell leukemia (HCL) is an uncommon low grade B cell leukemia that is marked by pancytopenia, splenomegaly, and characteristic cytoplasmic hairy projections. ...Many patients who show initial remission will relapse, and others with
Hairy cell leukemia (HCL) is an uncommon low grade B cell leukemia that is marked by pancytopenia, spleno
Hairy cell leukemia: a brief update on current knowledge and treatment prospects.
Puła A, Robak T. Puła A, et al. Curr Opin Oncol. 2021 Sep 1;33(5):412-419. doi: 10.1097/CCO.0000000000000771. Curr Opin Oncol. 2021. PMID: 34264896 Review.
PURPOSE OF REVIEW: This article provides a brief update on the recommended diagnosis and treatment strategies for patients with the classic form of hairy cell leukemia (HCL) and HCL variant (HCLv). RECENT FINDINGS: HCL is a chronic B-cell malign …
PURPOSE OF REVIEW: This article provides a brief update on the recommended diagnosis and treatment strategies for patients with the classic …
Management of hairy cell leukemia variant.
Robak T. Robak T. Leuk Lymphoma. 2011 Jun;52 Suppl 2:53-6. doi: 10.3109/10428194.2011.566392. Leuk Lymphoma. 2011. PMID: 21599606 Review.
Hairy cell leukemia variant (HCL-V) is now included in the World Health Organization (WHO) classification as a provisional entity and is no longer considered to be biologically related to classic HCL (HCL-C). ...A new generation of CD22-specific immuno
Hairy cell leukemia variant (HCL-V) is now included in the World Health Organization (WHO) classification as a p
35 results